A 12-month open-label trial of mycophenolate mofetil in multiple sclerosis

被引：0
|
作者：
Gogovska, L [1 ]
Ljapcev, R [1 ]
机构：
[1] Neurol Clin, Skopje, Macedonia
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S263 / S264
页数：2
相关论文
共 50 条
  • [21] An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients
    Solaro, C
    Lunardi, GL
    Capello, E
    Inglese, M
    Uccelli, MM
    Uccelli, A
    Mancardi, GL
    NEUROLOGY, 1998, 51 (02) : 609 - 611
  • [22] A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients FINE Trial
    Akman Demir, Gulsen
    Turkoglu, Recai
    Saip, Sabahattin
    Yuceyar, Nur
    Efendi, Husnu
    Turan, Omer Faruk
    Agan, Kadriye
    Terzi, Murat
    Boz, Cavit
    Tuncer, Asli
    Kocer, Belgin
    Kasap, Mithat
    Caliskan, Zeynep
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2019, 56 (04): : 253 - 257
  • [23] Frovatriptan for the prevention of menstrual migraine headaches: Results of a 12-month open-label safety and tolerability study
    Gammaitoni, A
    Ford, C
    Tobin, J
    Shaw, R
    Campbell, J
    NEUROLOGY, 2006, 66 (05) : A224 - A224
  • [24] Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: Analysis of the MOST database
    Salvadori, M
    Bock, A
    Chapman, J
    Dussol, B
    Fritsche, L
    Kliem, V
    Lebranchu, Y
    Oppenheimer, F
    Pohanka, E
    Tufveson, G
    Rosati, A
    Puig, X
    Corbetta, G
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (06) : 2464 - 2466
  • [25] Juvederm (R) Volbella (TM) in the perioral area: a 12-month prospective, multicenter, open-label study
    Eccleston, David
    Murphy, Diane K.
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2012, 5 : 167 - 172
  • [26] A Subgroup Analysis of a 12-month, Open-label Study to Evaluate Add-on Montelukast in Asthma Patients
    Virchow, J. C.
    Mehta, A.
    Ljungblad, L.
    Mitfessel, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [27] Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial
    Sinha, Aditi
    Puraswani, Mamta
    Kalaivani, Mani
    Goyal, Pragya
    Hari, Pankaj
    Bagga, Arvind
    KIDNEY INTERNATIONAL, 2019, 95 (01) : 210 - 218
  • [28] Malar Augmentation With a Polymethylmethacrylate-Enhanced Filler: Assessment of a 12-Month Open-Label Pilot Study
    Mills, Daniel C.
    Camp, Steven
    Mosser, Scott
    Sayeg, Ayoub
    Hurwitz, Dennis
    Ronel, Daniel
    AESTHETIC SURGERY JOURNAL, 2013, 33 (03) : 421 - 430
  • [29] Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial
    Brogan, Paul A.
    Arch, Barbara
    Hickey, Helen
    Anton, Jordi
    Iglesias, Este
    Baildam, Eileen
    Mahmood, Kamran
    Cleary, Gavin
    Moraitis, Elena
    Papadopoulou, Charalampia
    Beresford, Michael W.
    Riley, Phil
    Demir, Selcan
    Ozen, Seza
    Culeddu, Giovanna
    Hughes, Dyfrig A.
    Dolezalova, Pavla
    Hampson, Lisa, V
    Whitehead, John
    Jayne, David
    Ruperto, Nicola
    Eleftheriou, Despina
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (09) : 1673 - 1682
  • [30] FELBAMATE IN THE TREATMENT OF LENNOX-GASTAUT SYNDROME - RESULTS OF A 12-MONTH OPEN-LABEL STUDY FOLLOWING A RANDOMIZED CLINICAL-TRIAL
    DODSON, WE
    EPILEPSIA, 1993, 34 : S18 - S24
12345